Literature DB >> 33318318

LncRNA CYTOR affects the proliferation, cell cycle and apoptosis of hepatocellular carcinoma cells by regulating the miR-125b-5p/KIAA1522 axis.

Bo Hu1, Xiao-Bo Yang1, Xu Yang1, Xin-Ting Sang1.   

Abstract

We aimed to investigate whether lncRNA CYTOR could sponge miR-125b-5p to affect hepatocellular carcinoma (HCC) cells through targeting KIAA1522. The expression of CYTOR, miR-125b-5p and KIAA1522 in HCC cells was detected by Real-time quantitative polymerase chain reaction (RT-qPCR) analysis. KIAA1522 expression in HCC tissues was detected by immunohistochemistry. The proliferation, cell cycle and apoptosis of HCC cells after transfection were respectively detected by Cell Counting Kit-8 (CCK-8) assay and flow cytometry analysis, and related protein expression was determined by Western blot analysis. As a result, The Cancer Genome Atlas (TCGA) database indicated that expression of CYTOR and KIAA1522 was increased in HCC tissues and high expression of CYTOR and KIAA1522 was related to worse overall survival. MiR-125b-5p expression was decreased in HCC tissues, which was negatively correlated with the expression of CYTOR and KIAA1522. The proliferation and cell cycle of HCC cells were suppressed by CYTOR interference while promoted by miR-125b-5p interference and KIAA1522 overexpression. The apoptosis of HCC cells was promoted by CYTOR interference while inhibited by miR-125b-5p interference and KIAA1522 overexpression. In conclusion, CYTOR interference suppressed the proliferation and cell cycle, and promoted the apoptosis of HCC cells by regulating the miR-125b-5p/KIAA1522 axis.

Entities:  

Keywords:  apoptosis; hepatocellular carcinoma cells; lncRNA CYTOR; miR-125b-5p/KIAA1522 axis; proliferation

Mesh:

Substances:

Year:  2020        PMID: 33318318      PMCID: PMC7880333          DOI: 10.18632/aging.202306

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  26 in total

1.  Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.

Authors:  Haifang Wang; Wenxiang Chen; Peng Yang; Jun Zhou; Kaiyuan Wang; Qingchun Tao
Journal:  Cancer Biol Ther       Date:  2018-11-07       Impact factor: 4.742

Review 2.  MicroRNAs in cancer: biomarkers, functions and therapy.

Authors:  Josie Hayes; Pier Paolo Peruzzi; Sean Lawler
Journal:  Trends Mol Med       Date:  2014-07-12       Impact factor: 11.951

3.  MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K/AKT pathway.

Authors:  Shuo Liu; Qin Chen; Yue Wang
Journal:  Hum Cell       Date:  2019-10-11       Impact factor: 4.174

4.  A panel of protein markers for the early detection of lung cancer with bronchial brushing specimens.

Authors:  Yi-Zhen Liu; Yan-Yi Jiang; Bo-Shi Wang; Jia-Jie Hao; Li Shang; Tong-Tong Zhang; Jian Cao; Xin Xu; Qi-Min Zhan; Ming-Rong Wang
Journal:  Cancer Cytopathol       Date:  2014-07-09       Impact factor: 5.284

5.  UPF1 alleviates the progression of glioma via targeting lncRNA CYTOR.

Authors:  S-F Zou; X-Y Yang; J-B Li; H Ding; Y-Y Bao; J Xu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-11       Impact factor: 3.507

6.  MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.

Authors:  Lian Hui; Jingru Zhang; Xing Guo
Journal:  Biomed Pharmacother       Date:  2018-05-07       Impact factor: 6.529

7.  Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.

Authors:  E Morelli; E Leone; M E Gallo Cantafio; M T Di Martino; N Amodio; L Biamonte; A Gullà; U Foresta; M R Pitari; C Botta; M Rossi; A Neri; N C Munshi; K C Anderson; P Tagliaferri; P Tassone
Journal:  Leukemia       Date:  2015-05-19       Impact factor: 11.528

Review 8.  LncRNA-mediated regulation of cell signaling in cancer.

Authors:  W-X Peng; P Koirala; Y-Y Mo
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

9.  miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.

Authors:  Li-Li Mei; Wen-Jun Wang; Yun-Tan Qiu; Xiu-Feng Xie; Jie Bai; Zhi-Zhou Shi
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

10.  miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1.

Authors:  Shengni Hua; Yingyao Quan; Meixiao Zhan; Huaxin Liao; Yong Li; Ligong Lu
Journal:  Cancer Cell Int       Date:  2019-07-30       Impact factor: 5.722

View more
  11 in total

1.  mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes.

Authors:  Canbiao Wang; Shijie Qin; Wanwan Pan; Xuejia Shi; Hanyu Gao; Ping Jin; Xinyi Xia; Fei Ma
Journal:  Comput Struct Biotechnol J       Date:  2022-06-08       Impact factor: 6.155

2.  LINC00152 Drives a Competing Endogenous RNA Network in Human Hepatocellular Carcinoma.

Authors:  Rossella Pellegrino; Mirco Castoldi; Fabio Ticconi; Britta Skawran; Jan Budczies; Fabian Rose; Constantin Schwab; Kai Breuhahn; Ulf P Neumann; Nadine T Gaisa; Sven H Loosen; Tom Luedde; Ivan G Costa; Thomas Longerich
Journal:  Cells       Date:  2022-05-03       Impact factor: 7.666

3.  A Novel Nine-lncRNA Risk Signature Correlates With Immunotherapy in Hepatocellular Carcinoma.

Authors:  Ye Nie; Jianhui Li; Wenlong Wu; Dongnan Guo; Xinjun Lei; Tianchen Zhang; Yanfang Wang; Zhenzhen Mao; Xuan Zhang; Wenjie Song
Journal:  Front Oncol       Date:  2021-09-15       Impact factor: 6.244

4.  lncRNA cytoskeleton regulator reduces non‑small cell lung cancer radiosensitivity by downregulating miRNA‑206 and activating prothymosin α.

Authors:  Guoxiang Jiang; Honge Yu; Zhengliang Li; Fang Zhang
Journal:  Int J Oncol       Date:  2021-09-24       Impact factor: 5.650

5.  High expression of RRM2 mediated by non-coding RNAs correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.

Authors:  Guochao Mao; Lan Li; Changyou Shan; Baobao Liang; Li Ma; Shuqun Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-14

Review 6.  Long non-coding RNA LINC00152 in cancer: Roles, mechanisms, and chemotherapy and radiotherapy resistance.

Authors:  Shuang Li; Weiping Yao; Ruiqi Liu; Liang Gao; Yanwei Lu; Haibo Zhang; Xiaodong Liang
Journal:  Front Oncol       Date:  2022-08-10       Impact factor: 5.738

7.  Construction and validation of a ferroptosis-related long noncoding RNA signature in clear cell renal cell carcinoma.

Authors:  Zhenpeng Zhu; Cuijian Zhang; Jinqin Qian; Ninghan Feng; Weijie Zhu; Yang Wang; Yanqing Gong; Xuesong Li; Jian Lin; Liqun Zhou
Journal:  Cancer Cell Int       Date:  2022-09-14       Impact factor: 6.429

8.  Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma.

Authors:  Xiao Liu; Chiying Xiao; Kunyan Yue; Min Chen; Hang Zhou; Xiaokai Yan
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

Review 9.  EVA1A Plays an Important Role by Regulating Autophagy in Physiological and Pathological Processes.

Authors:  Shizhen Zhao; Honggang Wang
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

10.  Immunoautophagy-Related Long Noncoding RNA (IAR-lncRNA) Signature Predicts Survival in Hepatocellular Carcinoma.

Authors:  Yulu Wang; Fangfang Ge; Amit Sharma; Oliver Rudan; Maria F Setiawan; Maria A Gonzalez-Carmona; Miroslaw T Kornek; Christian P Strassburg; Matthias Schmid; Ingo G H Schmidt-Wolf
Journal:  Biology (Basel)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.